Cytokinetics (CYTK) Tops Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BE
8. FIX
9. PNFP
10. NDAQ

Go back to Cytokinetics (CYTK) Tops Q3 EPS by 7c

Cytokinetics, Inc. Reports Third Quarter 2015 Financial Results

October 29, 2015 4:00 PM EDT

Recently Announced Positive Top-line Results From COSMIC-HF; Data Demonstrated Statistically Significant Improvements in Several Pre-Specified Measures of Cardiac Function

Company Lowers 2015 R&D Expense Guidance

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) reported total research and development revenues for the third quarter of 2015 were $7.9 million, compared to $9.4 million during the same period in 2014.  The net loss for the third quarter was $8.8 million, or $0.23 per basic and diluted share. This is compared... More